The Healthcare and Science business of Thomson Reuters, US, has launched IDRAC Notes, an add-on commenting feature to IDRAC. This will allow colleagues within the same organisation to create, update and share comments attached to IDRAC PDF documents.
Designed from user feedback, IDRAC Notes seeks to improve collaboration and communication on regulatory affairs matters and improves information sharing and interpretation of regulatory requirements.
IDRAC, the regulatory intelligence solution of choice for the global pharmaceutical industry, allows organisations to get products to market faster and minimise regulatory risk by providing trusted information and analysis on the most up-to-date regulatory requirements. With the addition of IDRAC Notes, users now have the ability to capture, edit and share internal knowledge in a quick, easy and secure process.
